On the public citation graph

PD-1 and PD-1 ligands: from discovery to clinical application

0 signed · 1404 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

2 of the 125 references listed on this page are in the Retraction Watch database as retracted (export 2026-10-21): 10.1084/jem.20021466 (notice 2010-04-12), 10.4049/jimmunol.170.4.1830 (notice 2010-06-01).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1521-4141(200203)32:3<634::aid-immu634>3.0.co;2-9openalex-snapshot

PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2

inferredcites →https://doi.org/10.1002/ana.20514openalex-snapshot

A PD‐1 polymorphism is associated with disease progression in multiple sclerosis

inferredcites →https://doi.org/10.1002/art.10734openalex-snapshot

Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte–associated antigen 4, and programmed cell death 1 in primary Sjögren's syndrome

inferredcites →https://doi.org/10.1002/art.20040openalex-snapshot

Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus

inferredcites →https://doi.org/10.1002/art.20280openalex-snapshot

Association of the PD‐1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope

inferredcites →https://doi.org/10.1002/art.20436openalex-snapshot

Association of PDCD1 with susceptibility to systemic lupus erythematosus

inferredcites →https://doi.org/10.1002/art.20966openalex-snapshot

A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese

inferredcites →https://doi.org/10.1002/eji.200324228openalex-snapshot

Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

inferredcites →https://doi.org/10.1002/j.1460-2075.1992.tb05481.xopenalex-snapshot

Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

inferredcites →https://doi.org/10.1006/geno.1994.1562openalex-snapshot

Structure and Chromosomal Localization of the Human PD-1 Gene (PDCD1)

inferredcites →https://doi.org/10.1007/s00262-006-0266-zopenalex-snapshot

Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers

inferredcites →https://doi.org/10.1007/s00439-006-0309-8openalex-snapshot

PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children

inferredcites →https://doi.org/10.1007/s10875-005-0353-8openalex-snapshot

Fc Receptors and Their Role in Immune Regulation and Autoimmunity

inferredcites →https://doi.org/10.1007/s10875-006-9048-9openalex-snapshot

Programmed Death-1 Gene Polymorphisms in Patients With Systemic Lupus Erythematosus in Taiwan

inferredcites →https://doi.org/10.1016/0167-5273(96)02598-3openalex-snapshot

Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption

inferredcites →https://doi.org/10.1016/j.acthis.2006.01.003openalex-snapshot

Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance

inferredcites →https://doi.org/10.1016/j.cell.2006.01.022openalex-snapshot

Rejuvenating Exhausted T Cells during Chronic Viral Infection

inferredcites →https://doi.org/10.1016/j.clim.2005.10.017openalex-snapshot

Delivering PD-1 inhibitory signal concomitant with blocking ICOS co-stimulation suppresses lupus-like syndrome in autoimmune BXSB mice

inferredcites →https://doi.org/10.1016/j.clinthera.2006.11.020openalex-snapshot

Role of abatacept in the management of rheumatoid arthritis

inferredcites →https://doi.org/10.1016/j.coi.2005.09.013openalex-snapshot

Genetic susceptibility to type 1 diabetes

inferredcites →https://doi.org/10.1016/j.febslet.2004.07.083openalex-snapshot

PD‐1 inhibits T‐cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθ

inferredcites →https://doi.org/10.1016/j.humimm.2006.05.005openalex-snapshot

Decreased Risk for Myocardial Infarction and Lower Tumor Necrosis Factor–α Levels in Carriers of Variants of the PDCD1 Gene

inferredcites →https://doi.org/10.1016/j.ijcard.2006.05.014openalex-snapshot

Non-specific immunoadsorption in patients with dilated cardiomyopathy: Mechanisms and clinical effects

inferredcites →https://doi.org/10.1016/j.immuni.2005.05.005openalex-snapshot

Oscillating CD8+ T Cell Effector Functions after Antigen Recognition in the Liver

inferredcites →https://doi.org/10.1016/j.molmed.2005.05.001openalex-snapshot

Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy

inferredcites →https://doi.org/10.1016/j.oraloncology.2005.07.013openalex-snapshot

Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma

inferredcites →https://doi.org/10.1016/s0022-5347(18)34858-4openalex-snapshot

618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target

inferredcites →https://doi.org/10.1016/s0092-8674(01)00242-2openalex-snapshot

The Genetic Basis for Cardiomyopathy

inferredcites →https://doi.org/10.1016/s0140-6736(04)15468-8openalex-snapshot

Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy

inferredcites →https://doi.org/10.1016/s0165-2478(02)00142-6openalex-snapshot

Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues

inferredcites →https://doi.org/10.1016/s0735-1097(00)00568-4openalex-snapshot

Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy

inferredcites →https://doi.org/10.1016/s0735-1097(01)01794-6openalex-snapshot

Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption

inferredcites →https://doi.org/10.1016/s0887-7963(00)80157-1openalex-snapshot

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin 10 secretion

inferredcites →https://doi.org/10.1016/s1074-7613(00)00027-3openalex-snapshot

Spontaneous Autoimmune Disease in FcγRIIB-Deficient Mice Results from Strain-Specific Epistasis

inferredcites →https://doi.org/10.1016/s1074-7613(00)80089-8openalex-snapshot

Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor

inferredcites →https://doi.org/10.1016/s1074-7613(04)00051-2openalex-snapshot

Structural and Functional Analysis of the Costimulatory Receptor Programmed Death-1

inferredcites →https://doi.org/10.1016/s1074-7613(04)00114-1openalex-snapshot

Structural and Functional Analysis of the Costimulatory Receptor Programmed Death-1

inferredcites →https://doi.org/10.1038/70932openalex-snapshot

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

inferredcites →https://doi.org/10.1038/85330openalex-snapshot

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

inferredcites →https://doi.org/10.1038/nature03954openalex-snapshot

Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance

inferredcites →https://doi.org/10.1038/nature04444openalex-snapshot

Restoring function in exhausted CD8 T cells during chronic viral infection

inferredcites →https://doi.org/10.1038/nature05115openalex-snapshot

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

inferredcites →https://doi.org/10.1038/ncprheum0345openalex-snapshot

Drug Insight: abatacept for the treatment of rheumatoid arthritis

inferredcites →https://doi.org/10.1038/ng1020openalex-snapshot

A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans

inferredcites →https://doi.org/10.1038/ng1267openalex-snapshot

An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis

inferredcites →https://doi.org/10.1038/ng1268openalex-snapshot

A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis

inferredcites →https://doi.org/10.1038/ni0103-19openalex-snapshot

The dual-function CD150 receptor subfamily: the viral attraction

inferredcites →https://doi.org/10.1038/ni1106openalex-snapshot

E3 ubiquitin ligases as T cell anergy factors

inferredcites →https://doi.org/10.1038/ni1165openalex-snapshot

Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4

inferredcites →https://doi.org/10.1038/ni944openalex-snapshot

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

inferredcites →https://doi.org/10.1038/nm1482openalex-snapshot

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

inferredcites →https://doi.org/10.1038/nm1517openalex-snapshot

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

inferredcites →https://doi.org/10.1038/nm730openalex-snapshot

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

inferredcites →https://doi.org/10.1038/nm863openalex-snapshot

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

inferredcites →https://doi.org/10.1038/nm955openalex-snapshot

Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

inferredcites →https://doi.org/10.1038/nrc1819openalex-snapshot

Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis

inferredcites →https://doi.org/10.1038/sj.emboj.7601146openalex-snapshot

T‐cell tolerance or function is determined by combinatorial costimulatory signals

inferredcites →https://doi.org/10.1038/sj.gene.6364223openalex-snapshot

PDCD1: a tissue-specific susceptibility locus for inherited inflammatory disorders

inferredcites →https://doi.org/10.1038/sj.gene.6364360openalex-snapshot

No evidence of association between genetic variants of the PDCD1 ligands and SLE

inferredcites →https://doi.org/10.1046/j.1399-0039.2003.00136.xopenalex-snapshot

Association of a putative regulatory polymorphism in the PD‐1 gene with susceptibility to type 1 diabetes

inferredcites →https://doi.org/10.1056/nejmoa063842openalex-snapshot

Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412

inferredcites →https://doi.org/10.1073/pnas.0406351101openalex-snapshot

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

inferredcites →https://doi.org/10.1073/pnas.0505497102openalex-snapshot

Establishment of NOD- Pdcd1 -/- mice as an efficient animal model of type I diabetes

inferredcites →https://doi.org/10.1073/pnas.0611533104openalex-snapshot

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer

inferredcites →https://doi.org/10.1073/pnas.0931259100openalex-snapshot

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

inferredcites →https://doi.org/10.1073/pnas.192461099openalex-snapshot

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

inferredcites →https://doi.org/10.1073/pnas.231486598openalex-snapshot

PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine

inferredcites →https://doi.org/10.1080/08916930500124072openalex-snapshot

PD-1/PD-L pathway and autoimmunity

inferredcites →https://doi.org/10.1084/jem.160.2.521openalex-snapshot

Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.

inferredcites →https://doi.org/10.1084/jem.192.7.1027openalex-snapshot

Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

inferredcites →https://doi.org/10.1084/jem.193.7.839openalex-snapshot

B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells

inferredcites →https://doi.org/10.1084/jem.20021466openalex-snapshot

RETRACTED: Cross-linking the B7 Family Molecule B7-DC Directly Activates Immune Functions of Dendritic Cells

inferredcites →https://doi.org/10.1084/jem.20022125openalex-snapshot

The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice

inferredcites →https://doi.org/10.1084/jem.20022235openalex-snapshot

PD-1 Inhibits Antiviral Immunity at the Effector Phase in the Liver

inferredcites →https://doi.org/10.1084/jem.20050019openalex-snapshot

A critical role for the programmed death ligand 1 in fetomaternal tolerance

inferredcites →https://doi.org/10.1084/jem.20050072openalex-snapshot

In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses

inferredcites →https://doi.org/10.1084/jem.20051776openalex-snapshot

Tissue expression of PD-L1 mediates peripheral T cell tolerance

inferredcites →https://doi.org/10.1084/jem.20051984openalex-snapshot

Hydronephrosis associated with antiurothelial and antinuclear autoantibodies in BALB/c-Fcgr2b −/− Pdcd1 −/− mice

inferredcites →https://doi.org/10.1084/jem.20061496openalex-snapshot

PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

inferredcites →https://doi.org/10.1093/intimm/10.10.1563openalex-snapshot

Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses

inferredcites →https://doi.org/10.1093/intimm/8.5.765openalex-snapshot

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

inferredcites →https://doi.org/10.1093/intimm/8.5.773openalex-snapshot

Developmentally regulated expression of the PD-1 protein on the surface of double-negative(CD4–CD8–) thymocytes

inferredcites →https://doi.org/10.1093/intimm/dxh121openalex-snapshot

Suppression of expression and function of negative immune regulator PD-1 by certain pattern recognition and cytokine receptor signals associated with immune system danger

inferredcites →https://doi.org/10.1093/intimm/dxh194openalex-snapshot

PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells

inferredcites →https://doi.org/10.1095/biolreprod.102.010058openalex-snapshot

B7 Family Molecules Are Favorably Positioned at the Human Maternal-Fetal Interface1

inferredcites →https://doi.org/10.1111/j.1365-2893.2006.00746.xopenalex-snapshot

B7‐H1 expression is upregulated in peripheral blood CD14+ monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL‐10 levels

inferredcites →https://doi.org/10.1111/j.1572-0241.2006.00948.xopenalex-snapshot

Expression of PD-1, PD-L1, and PD-L2 in the Liver in Autoimmune Liver Diseases

inferredcites →https://doi.org/10.1126/science.291.5502.319openalex-snapshot

Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice

inferredcites →https://doi.org/10.1126/science.8342023openalex-snapshot

Signal Sequence Trap: a Cloning Strategy for Secreted Proteins and Type I Membrane Proteins

inferredcites →https://doi.org/10.1128/jvi.01177-06openalex-snapshot

PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion

inferredcites →https://doi.org/10.1128/jvi.02021-06openalex-snapshot

Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression

inferredcites →https://doi.org/10.1128/mcb.25.21.9543-9553.2005openalex-snapshot

CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms

inferredcites →https://doi.org/10.1146/annurev.immunol.12.1.991openalex-snapshot

Tolerance, Danger and the Extended Family

inferredcites →https://doi.org/10.1146/annurev.immunol.17.1.875openalex-snapshot

REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS

inferredcites →https://doi.org/10.1146/annurev.immunol.19.1.275openalex-snapshot

IgG Fc Receptors

inferredcites →https://doi.org/10.1146/annurev.immunol.23.021704.115611openalex-snapshot

THE B7 FAMILY REVISITED

inferredcites →https://doi.org/10.1146/annurev.immunol.23.021704.115643openalex-snapshot

THE NOD MOUSE: A Model of Immune Dysregulation

inferredcites →https://doi.org/10.1146/annurev.iy.12.040194.005015openalex-snapshot

Tolerance, Danger, and the Extended Family

inferredcites →https://doi.org/10.1158/0008-5472.1089.65.3openalex-snapshot

Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity

inferredcites →https://doi.org/10.1158/0008-5472.can-03-3259openalex-snapshot

PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells

inferredcites →https://doi.org/10.1158/0008-5472.can-05-4303openalex-snapshot

Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up

inferredcites →https://doi.org/10.1158/1078-0432.ccr-04-0428openalex-snapshot

B7-H1 Expression on Non-Small Cell Lung Cancer Cells and Its Relationship with Tumor-Infiltrating Lymphocytes and Their PD-1 Expression

inferredcites →https://doi.org/10.1158/1078-0432.ccr-04-1469openalex-snapshot

Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer

inferredcites →https://doi.org/10.1158/1078-0432.ccr-06-2599openalex-snapshot

PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma

inferredcites →https://doi.org/10.1158/1078-0432.ccr-06-2746openalex-snapshot

Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer

inferredcites →https://doi.org/10.1161/circulationaha.106.635664openalex-snapshot

Cardiac Troponin I but Not Cardiac Troponin T Induces Severe Autoimmune Inflammation in the Myocardium

inferredcites →https://doi.org/10.1182/blood-2002-07-2254openalex-snapshot

Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells

inferredcites →https://doi.org/10.1182/blood-2002-10-3065openalex-snapshot

B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression

inferredcites →https://doi.org/10.1182/blood.v97.6.1809openalex-snapshot

B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function

inferredcites →https://doi.org/10.1186/ar2071openalex-snapshot

Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population

inferredcites →https://doi.org/10.1200/jco.2005.01.109openalex-snapshot

Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

inferredcites →https://doi.org/10.1245/aso.2005.03.536openalex-snapshot

Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study

inferredcites →https://doi.org/10.1593/neo.05733openalex-snapshot

The B7-H1 (PD-L1) T Lymphocyte-Inhibitory Molecule Is Expressed in Breast Cancer Patients with Infiltrating Ductal Carcinoma: Correlation with Important High-Risk Prognostic Factors

inferredcites →https://doi.org/10.4049/jimmunol.169.10.5538openalex-snapshot

Expression of Programmed Death 1 Ligands by Murine T Cells and APC

inferredcites →https://doi.org/10.4049/jimmunol.169.11.6546openalex-snapshot

Programmed Death-1 Targeting Can Promote Allograft Survival

inferredcites →https://doi.org/10.4049/jimmunol.170.3.1257openalex-snapshot

Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production

inferredcites →https://doi.org/10.4049/jimmunol.170.4.1830openalex-snapshot

Naturally Occurring Human IgM Antibody That Binds B7-DC and Potentiates T Cell Stimulation by Dendritic Cells

inferredcites →https://doi.org/10.4049/jimmunol.170.7.3637openalex-snapshot

B7-H1 (Programmed Death-1 Ligand) on Dendritic Cells Is Involved in the Induction and Maintenance of T Cell Anergy

inferredcites →https://doi.org/10.4049/jimmunol.173.8.4919openalex-snapshot

Blocking Programmed Death-1 Ligand-PD-1 Interactions by Local Gene Therapy Results in Enhancement of Antitumor Effect of Secondary Lymphoid Tissue Chemokine

inferredcites →https://doi.org/10.4049/jimmunol.174.4.1888openalex-snapshot

Prevention of Experimental Autoimmune Encephalomyelitis by Transfer of Embryonic Stem Cell-Derived Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein Peptide along with TRAIL or Programmed Death-1 Ligand

inferredcites →https://doi.org/10.4049/jimmunol.175.2.1145openalex-snapshot

Human Rhinoviruses Inhibit the Accessory Function of Dendritic Cells by Inducing Sialoadhesin and B7-H1 Expression

inferredcites →https://doi.org/10.4049/jimmunol.175.9.5774openalex-snapshot

Differential Effects of B and T Lymphocyte Attenuator and Programmed Death-1 on Acceptance of Partially versus Fully MHC-Mismatched Cardiac Allografts

inferredcites →https://doi.org/10.4049/jimmunol.176.5.2808openalex-snapshot

Regulated Compartmentalization of Programmed Cell Death-1 Discriminates CD4+CD25+ Resting Regulatory T Cells from Activated T Cells

inferredcites →https://doi.org/10.4049/jimmunol.176.5.3000openalex-snapshot

Expression of B7-H1 on Gastric Epithelial Cells: Its Potential Role in Regulating T Cells during Helicobacter pylori Infection

inferredcites →https://doi.org/10.4049/jimmunol.177.12.8844openalex-snapshot

Aberrant Regulation of Synovial T Cell Activation by Soluble Costimulatory Molecules in Rheumatoid Arthritis

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4195069openalex-extracted

Phase I/II Trial of Cabozantinib Plus Durvalumab in Advanced Gastroesophageal Cancer and Other Gastrointestinal Malignancies (CAMILLA): Phase Ib Safety and Efficacy Results

inferred← citeshttps://doi.org/10.1001/jama.2016.4059openalex-snapshot

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

inferred← citeshttps://doi.org/10.1001/jamadermatol.2015.1916openalex-snapshot

Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression

inferred← citeshttps://doi.org/10.1002/1878-0261.13103openalex-snapshot

PD‐1‐induced T cell exhaustion is controlled by a Drp1‐dependent mechanism

inferred← citeshttps://doi.org/10.1002/2211-5463.12865openalex-snapshot

CD279 mediates the homeostasis and survival of regulatory T cells by enhancing T cell and macrophage interactions

inferred← citeshttps://doi.org/10.1002/9781118354599.ch30openalex-snapshot

Signal Converter Proteins

inferred← citeshttps://doi.org/10.1002/9781118468791.ch29openalex-snapshot

Immunologic Approaches to Lung Cancer Therapy

inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm068openalex-snapshot

Cancer Immunotherapy

inferred← citeshttps://doi.org/10.1002/9781119697473.ch15openalex-snapshot

Other Disorders with Type 1 Diabetes and Atypical Phenotypes

inferred← citeshttps://doi.org/10.1002/adhm.202002104openalex-snapshot

Immune Checkpoint Inhibitor‐Based Strategies for Synergistic Cancer Therapy

inferred← citeshttps://doi.org/10.1002/adtp.202500120openalex-snapshot

Injectable Immune‐Engineered Hydrogel Niche Remote from the Immune Suppressed Tumor Microenvironment for Cancer Immunotherapy

inferred← citeshttps://doi.org/10.1002/advs.202303175openalex-snapshot

Challenges Coexist with Opportunities: Spatial Heterogeneity Expression of PD‐L1 in Cancer Therapy

inferred← citeshttps://doi.org/10.1002/ags3.12440openalex-snapshot

Recent developments in cancer research: Expectations for a new remedy

inferred← citeshttps://doi.org/10.1002/art.40164openalex-snapshot

Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis

inferred← citeshttps://doi.org/10.1002/cam4.3152openalex-snapshot

Effects of adaptive immune cell therapy on the immune cell profile in patients with advanced gastric cancer

inferred← citeshttps://doi.org/10.1002/cam4.4190openalex-snapshot

PD‐1/PD‐L1 inhibitors‐based treatment for advanced renal cell carcinoma: Mechanisms affecting efficacy and combination therapies

inferred← citeshttps://doi.org/10.1002/cam4.5747openalex-snapshot

CD169 + sinus macrophages in regional lymph nodes do not predict mismatch‐repair status of patients with colorectal cancer

inferred← citeshttps://doi.org/10.1002/cam4.7097openalex-snapshot

Transcriptional profile and immune infiltration in colorectal cancer reveal the significance of inducible T‐cell costimulator as a crucial immune checkpoint molecule

inferred← citeshttps://doi.org/10.1002/cbf.3827openalex-snapshot

Structure of PD1 and its mechanism in the treatment of autoimmune diseases

inferred← citeshttps://doi.org/10.1002/cbic.202400264openalex-snapshot

Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth In Vivo

inferred← citeshttps://doi.org/10.1002/ccr3.4056openalex-snapshot

Tumor immune tissue response to a solitary fibrous tumor treated with pazopanib

inferred← citeshttps://doi.org/10.1002/cmdc.202000221openalex-snapshot

The Synthesis and Anti‐tumour Properties of Poly Ethoxy Ethyl Glycinamide (PEE−G) Scaffolds with Multiple PD‐1 Peptides Attached

inferred← citeshttps://doi.org/10.1002/cncr.33690openalex-snapshot

A phase 1b/2 study of azacitidine with PD‐L1 antibody avelumab in relapsed/refractory acute myeloid leukemia

inferred← citeshttps://doi.org/10.1002/dmrr.2552openalex-snapshot

PD‐L1 gene polymorphisms and low serum level of PD‐L1 protein are associated to type 1 diabetes in Chile

inferred← citeshttps://doi.org/10.1002/eji.200839103openalex-snapshot

Induction of Treg by monocyte‐derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD‐L1

inferred← citeshttps://doi.org/10.1002/eji.201040959openalex-snapshot

Expression and function of PD‐1 in human γδ T cells that recognize phosphoantigens

inferred← citeshttps://doi.org/10.1002/eji.201041359openalex-snapshot

Intranasal but not intravenous delivery of the adjuvant α‐galactosylceramide permits repeated stimulation of natural killer T cells in the lung

inferred← citeshttps://doi.org/10.1002/eji.201948399openalex-snapshot

Relationship between T cell receptor clonotype and PD‐1 expression of tumor‐infiltrating lymphocytes in colorectal cancer

inferred← citeshttps://doi.org/10.1002/hep.23173openalex-snapshot

Chronically inflamed livers up-regulate expression of inhibitory B7 family members #

inferred← citeshttps://doi.org/10.1002/ijc.33415openalex-snapshot

Targeting CTLA ‐4 in cancer: Is it the ideal companion for PD ‐1 blockade immunotherapy combinations?

inferred← citeshttps://doi.org/10.1002/jcb.27713openalex-snapshot

Oncostatic treatment effect of triple negative breast cancer cell line with copper (I)‐nicotinate complex

inferred← citeshttps://doi.org/10.1002/jcp.25765openalex-snapshot

Current Status and Prospective Regarding the Therapeutic Potential of Natural Autoantibodies in Cancer Therapy

inferred← citeshttps://doi.org/10.1002/jcp.26134openalex-snapshot

Increased expression of PD‐L1 and PD‐L2 in dermal fibroblasts from alopecia areata mice

inferred← citeshttps://doi.org/10.1002/jcp.30625openalex-snapshot

CircRNA–miRNA networks in regulating bone disease

inferred← citeshttps://doi.org/10.1002/jcp.30645openalex-snapshot

Tumor‐derived exosomal PD‐L1 in progression of cancer and immunotherapy

inferred← citeshttps://doi.org/10.1002/jcph.591openalex-snapshot

Immune Checkpoint inhibitors: An introduction to the next‐generation cancer immunotherapy

inferred← citeshttps://doi.org/10.1002/jnr.22181openalex-snapshot

Down‐modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis

inferred← citeshttps://doi.org/10.1002/lt.26336openalex-snapshot

Increased Expressions of Programmed Death Ligand 1 and Galectin 9 in Transplant Recipients Who Achieved Tolerance After Immunosuppression Withdrawal

inferred← citeshttps://doi.org/10.1002/mco2.61openalex-snapshot

Clinical benefit of neoadjuvant anti‐PD‐1/PD‐L1 utilization among different tumors

inferred← citeshttps://doi.org/10.1002/med.21404openalex-snapshot

Metastatic Melanoma: Insights Into the Evolution of the Treatments and Future Challenges

inferred← citeshttps://doi.org/10.1002/path.4259openalex-snapshot

New drug targets in metastatic melanoma

inferred← citeshttps://doi.org/10.1002/path.5038openalex-snapshot

Established, emerging and elusive molecular targets in the treatment of lung cancer

inferred← citeshttps://doi.org/10.1002/pbc.25284openalex-snapshot

The role of programmed cell death‐1 (PD‐1) and its ligands in pediatric cancer

inferred← citeshttps://doi.org/10.1002/pbc.26682openalex-snapshot

Fatal orthotopic liver transplant organ rejection induced by a checkpoint inhibitor in two patients with refractory, metastatic hepatocellular carcinoma

inferred← citeshttps://doi.org/10.1002/pds.5108openalex-snapshot

Analysis of immune‐related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database

inferred← citeshttps://doi.org/10.1002/slct.202302813openalex-snapshot

Molecular modeling studies of Indoline Scaffold derivatives as PD‐1/PD‐L1 pathway inhibitors by QSAR, molecular docking and molecular dynamics simulation techniques

inferred← citeshttps://doi.org/10.1002/smll.202205131openalex-snapshot

Reactivation of Anticancer Immunity by Resetting Interorgan Crosstalk in Immune‐Suppressive Cells with a Nanoparticulated Anti‐Inflammatory Drug

inferred← citeshttps://doi.org/10.1002/wsbm.1210openalex-snapshot

Developing melanoma therapeutics: overview and update

inferred← citeshttps://doi.org/10.1007/82_2010_116openalex-snapshot

Role of PD-1 in Regulating T-Cell Immunity

inferred← citeshttps://doi.org/10.1007/82_2017_67openalex-snapshot

Role of PD-1 in Immunity and Diseases

inferred← citeshttps://doi.org/10.1007/978-0-387-84828-0_30openalex-snapshot

B7 and CD28 Families

inferred← citeshttps://doi.org/10.1007/978-1-0716-1278-1_4openalex-snapshot

Detection of Programmed Cell Death Ligand 1 Expression in Lung Cancer Clinical Samples by an Automated Immunohistochemistry System

inferred← citeshttps://doi.org/10.1007/978-1-0716-4734-9_5openalex-snapshot

Evaluation of Immune Checkpoint Inhibitors in a Jurkat-Based Transcriptional Reporter System: A Cell-Based Reporter Platform for Evaluation of Immune Checkpoint Inhibitors

inferred← citeshttps://doi.org/10.1007/978-1-4419-0717-2_39openalex-snapshot

Anti-Programmed Death 1 (PD1)

inferred← citeshttps://doi.org/10.1007/978-1-4419-7107-4_27openalex-snapshot

Inflammation and Liver Injury

inferred← citeshttps://doi.org/10.1007/978-1-4614-5441-0_16openalex-snapshot

Immunobiology of β-Cell Destruction

inferred← citeshttps://doi.org/10.1007/978-1-4614-5847-0_14openalex-snapshot

Activation of Immune-Mediated Tumor Cell Death by Chemotherapy

inferred← citeshttps://doi.org/10.1007/978-1-4614-6613-0_39-2openalex-snapshot

Anti-Programmed Death 1 (PD1)

inferred← citeshttps://doi.org/10.1007/978-1-4939-2724-1_7openalex-snapshot

Inflammation and Lung Cancer: Addressing Inflammation with Immunotherapy

inferred← citeshttps://doi.org/10.1007/978-1-84800-165-7_17openalex-snapshot

Immunobiology and Immune-Based Therapies of Melanoma

inferred← citeshttps://doi.org/10.1007/978-3-030-18797-2_2openalex-snapshot

Non-melanoma Skin Cancer and Cutaneous Melanoma from the Oncological Point of View

inferred← citeshttps://doi.org/10.1007/978-3-030-31471-2_14openalex-snapshot

Melanoma

inferred← citeshttps://doi.org/10.1007/978-3-030-36214-0_9openalex-snapshot

Cancer Stem Cell Niche and Immune-Active Tumor Microenvironment in Testicular Germ Cell Tumors

inferred← citeshttps://doi.org/10.1007/978-3-030-50287-4_6openalex-snapshot

Overcoming Cancer Tolerance with Immune Checkpoint Blockade

inferred← citeshttps://doi.org/10.1007/978-3-030-78338-9_12openalex-snapshot

Multifunctional Gold Nanostars for Sensitive Detection, Photothermal Treatment and Immunotherapy of Brain Tumor

inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_162-1openalex-snapshot

Immune Checkpoint Therapy: A New Opportunity for Cancer Treatment

inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_218-1openalex-snapshot

Immunotherapy in Gastrointestinal Malignancies

inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_218-2openalex-snapshot

Immunotherapy for Gastrointestinal Malignancies

inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_241-1openalex-snapshot

Immunotherapy for Ocular Tumors

inferred← citeshttps://doi.org/10.1007/978-3-031-05724-3_25openalex-snapshot

Mechanisms and Evidence on Pancreatic Cancer Prevention

inferred← citeshttps://doi.org/10.1007/978-3-031-15130-9_150openalex-snapshot

Immunotherapy for Melanoma

inferred← citeshttps://doi.org/10.1007/978-3-031-63366-9_15openalex-snapshot

Stem Cell Transplantation and Cellular Immunotherapies for Pediatric AML

inferred← citeshttps://doi.org/10.1007/978-3-031-68505-7_23openalex-snapshot

Targeting the Immune Checkpoint in Bladder Cancer

inferred← citeshttps://doi.org/10.1007/978-3-031-83030-3_1openalex-snapshot

Introduction

inferred← citeshttps://doi.org/10.1007/978-3-032-00765-0_162openalex-snapshot

Immune Checkpoint Therapy: A New Opportunity for Cancer Treatment

inferred← citeshttps://doi.org/10.1007/978-3-032-00769-8_218openalex-snapshot

Immunotherapy for Gastrointestinal Malignancies

inferred← citeshttps://doi.org/10.1007/978-3-032-00769-8_241openalex-snapshot

Immunotherapy for Ocular Tumors

inferred← citeshttps://doi.org/10.1007/978-3-032-24071-2_7openalex-snapshot

Molecular Biomarkers in Urothelial Carcinoma: Current Insights and Future Directions

inferred← citeshttps://doi.org/10.1007/978-3-0348-0620-6_101-1openalex-snapshot

Co-stimulatory Receptors

inferred← citeshttps://doi.org/10.1007/978-3-0348-0726-5_9openalex-snapshot

On the Role of Co-inhibitory Molecules in Dendritic Cell: T Helper Cell Coculture Assays Aimed to Detect Chemical-Induced Contact Allergy

inferred← citeshttps://doi.org/10.1007/978-3-319-22473-2_6openalex-snapshot

Therapeutic Antibodies in Cancer Therapy

inferred← citeshttps://doi.org/10.1007/978-3-319-29785-9_51openalex-snapshot

Immunobiology and Immune Based Therapies of Melanoma

inferred← citeshttps://doi.org/10.1007/978-3-319-32805-8_6openalex-snapshot

Therapeutic Antibodies in Cancer Therapy

inferred← citeshttps://doi.org/10.1007/978-3-319-48066-4_12openalex-snapshot

Nivolumab

inferred← citeshttps://doi.org/10.1007/978-3-319-62431-0_23openalex-snapshot

PD-L1 and Other Immunological Diagnosis Tools

inferred← citeshttps://doi.org/10.1007/978-3-319-74920-4_6openalex-snapshot

Photoimmunotherapy for Cancer Metastasis Treatment

inferred← citeshttps://doi.org/10.1007/978-3-319-95228-4_29openalex-snapshot

Predictive Biomarkers and Targeted Therapies in Immuno-oncology

inferred← citeshttps://doi.org/10.1007/978-3-540-45021-4_31openalex-snapshot

Cancer of the Kidney

inferred← citeshttps://doi.org/10.1007/978-3-662-44946-2_6openalex-snapshot

Overcoming Cancer Tolerance with Immune Checkpoint Blockade

inferred← citeshttps://doi.org/10.1007/978-3-7643-8550-7_101openalex-snapshot

Costimulatory Receptors

inferred← citeshttps://doi.org/10.1007/978-4-431-55855-2_5openalex-snapshot

T Cells

inferred← citeshttps://doi.org/10.1007/978-90-481-3271-3_24openalex-snapshot

Immunology of β-Cell Destruction

inferred← citeshttps://doi.org/10.1007/978-94-007-4216-1_7openalex-snapshot

Polarised Transfer of Proteins Through the Syncytiotrophobalst and Tissue Culture Cell Lines

inferred← citeshttps://doi.org/10.1007/978-981-10-7941-2_12openalex-snapshot

Molecular Targeted Therapy for Epithelial Ovarian Cancer

inferred← citeshttps://doi.org/10.1007/978-981-13-8906-1_14openalex-snapshot

Nivolumab (Opdivo)

inferred← citeshttps://doi.org/10.1007/978-981-15-3266-5_3openalex-snapshot

Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond

inferred← citeshttps://doi.org/10.1007/978-981-16-2870-2_15openalex-snapshot

Immunotherapy for Pancreatic Cancer and Cholangiocarcinoma

inferred← citeshttps://doi.org/10.1007/978-981-19-3995-2_2openalex-snapshot

Immunology: How Does the Immune System Affect the Development of Pulmonary TB? How Does an Understanding of TB Immunology Help Clinicians Manage their Patients with Pulmonary TB?

inferred← citeshttps://doi.org/10.1007/978-981-19-4711-7_6openalex-snapshot

Personalized Treatment in Immunotherapy for Gynecologic Cancer

inferred← citeshttps://doi.org/10.1007/978-981-32-9717-3_2openalex-snapshot

The CD28–B7 Family of Co-signaling Molecules

inferred← citeshttps://doi.org/10.1007/978-981-32-9717-3_8openalex-snapshot

Stimulatory and Inhibitory Co-signals in Autoimmunity

inferred← citeshttps://doi.org/10.1007/978-981-32-9816-3_20openalex-snapshot

New Emerging Molecules in Cancer Research Which Hold Promise in Current Era

inferred← citeshttps://doi.org/10.1007/978-981-95-0946-1_9openalex-snapshot

Immune Checkpoint Inhibitors in Endometrial Cancer: Current Status and Future Perspectives

inferred← citeshttps://doi.org/10.1007/s00005-013-0219-0openalex-snapshot

Immune Exhaustion and Immune Senescence: Two Distinct Pathways for HBV Vaccine Failure During HCV and/or HIV Infection

inferred← citeshttps://doi.org/10.1007/s00018-020-03466-2openalex-snapshot

Adenosine-to-inosine RNA editing in the immune system: friend or foe?

inferred← citeshttps://doi.org/10.1007/s00018-020-03637-1openalex-snapshot

Immune landscape and therapeutic strategies: new insights into PD-L1 in tumors

inferred← citeshttps://doi.org/10.1007/s00018-020-03737-yopenalex-snapshot

Transcriptional and epigenetic regulation of PD-1 expression

inferred← citeshttps://doi.org/10.1007/s00092-022-5501-1openalex-snapshot

Immunbedingte Toxizitäten behandeln

inferred← citeshttps://doi.org/10.1007/s00228-024-03644-2openalex-snapshot

Progress of PD-1/PD-L1 inhibitor combination therapy in immune treatment for HER2-positive tumors

inferred← citeshttps://doi.org/10.1007/s00262-011-1007-5openalex-snapshot

Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma

inferred← citeshttps://doi.org/10.1007/s00262-017-1979-xopenalex-snapshot

The PD-L1/PD-1 pathway promotes dysfunction, but not “exhaustion”, in tumor-responding T cells from pleural effusions in lung cancer patients

inferred← citeshttps://doi.org/10.1007/s00262-017-1987-xopenalex-snapshot

Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy

inferred← citeshttps://doi.org/10.1007/s00262-017-2103-yopenalex-snapshot

High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer

inferred← citeshttps://doi.org/10.1007/s00262-018-2260-7openalex-snapshot

Recurrent grade 4 panuveitis with serous retinal detachment related to nivolumab treatment in a patient with metastatic renal cell carcinoma

inferred← citeshttps://doi.org/10.1007/s00262-019-02321-zopenalex-snapshot

Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancer

inferred← citeshttps://doi.org/10.1007/s00262-019-02427-4openalex-snapshot

Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma

inferred← citeshttps://doi.org/10.1007/s00262-021-03130-zopenalex-snapshot

PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression

inferred← citeshttps://doi.org/10.1007/s00262-023-03431-5openalex-snapshot

Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, with special reference to PD-1 expression

inferred← citeshttps://doi.org/10.1007/s00262-023-03543-yopenalex-snapshot

An alternatively spliced PD-L1 isoform PD-L1∆3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy response

inferred← citeshttps://doi.org/10.1007/s00277-020-04084-5openalex-snapshot

Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders

inferred← citeshttps://doi.org/10.1007/s00281-009-0190-3openalex-snapshot

Costimulation of Th17 cells: adding fuel or putting out the fire in the inflamed gut?

inferred← citeshttps://doi.org/10.1007/s00296-009-1249-0openalex-snapshot

The effects of PDL-Ig on collagen-induced arthritis

inferred← citeshttps://doi.org/10.1007/s00431-009-1002-4openalex-snapshot

Programmed death-1 (PD-1) gene polymorphisms lodged in the genetic predispositions of Kawasaki Disease

inferred← citeshttps://doi.org/10.1007/s00441-020-03351-1openalex-snapshot

Immune regulation in renal inflammation

inferred← citeshttps://doi.org/10.1007/s10147-016-0959-zopenalex-snapshot

PD-1/PD-L1 blockade in cancer treatment: perspectives and issues

inferred← citeshttps://doi.org/10.1007/s10147-019-01520-zopenalex-snapshot

Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology

inferred← citeshttps://doi.org/10.1007/s10147-019-01588-7openalex-snapshot

Current issues and perspectives in PD-1 blockade cancer immunotherapy

inferred← citeshttps://doi.org/10.1007/s10147-025-02721-5openalex-snapshot

Lenvatinib enhances antitumor immunity of anti-PD-1 antibody

inferred← citeshttps://doi.org/10.1007/s10269-017-2706-4openalex-snapshot

Résistance primaire et résistance acquise aux inhibiteurs PD-1

inferred← citeshttps://doi.org/10.1007/s10549-019-05371-0openalex-snapshot

Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis

inferred← citeshttps://doi.org/10.1007/s10549-021-06384-4openalex-snapshot

A HER2 target antibody drug conjugate combined with anti-PD-(L)1 treatment eliminates hHER2+ tumors in hPD-1 transgenic mouse model and contributes immune memory formation

inferred← citeshttps://doi.org/10.1007/s10637-016-0371-6openalex-snapshot

Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors

inferred← citeshttps://doi.org/10.1007/s10637-018-0678-6openalex-snapshot

A novel humanized anti-PD-1 monoclonal antibody potentiates therapy in oral squamous cell carcinoma

inferred← citeshttps://doi.org/10.1007/s10753-010-9282-4openalex-snapshot

Study of Programmed Cell Death 1 (PDCD1) Gene Polymorphims in Iranian Patients with Ankylosing Spondylitis

inferred← citeshttps://doi.org/10.1007/s10875-008-9272-6openalex-snapshot

Polymorphisms of PTPN11 Coding SHP-2 as Biomarkers for Ulcerative Colitis Susceptibility in the Japanese Population

inferred← citeshttps://doi.org/10.1007/s10989-025-10707-0openalex-snapshot

Development of Novel Short Peptide Inhibitor Targeted to Immune Checkpoint PD-1 LBD

inferred← citeshttps://doi.org/10.1007/s11030-022-10509-2openalex-snapshot

Progress in programmed cell death-1/programmed cell death-ligand 1 pathway inhibitors and binding mode analysis

inferred← citeshttps://doi.org/10.1007/s11030-025-11465-3openalex-snapshot

Computational screening of Viola odorata cyclotides identifies Phyb C as potential PD-1 inhibitor for cancer immunotherapy

inferred← citeshttps://doi.org/10.1007/s11033-026-12268-xopenalex-snapshot

eIF6 affects the occurrence and development of esophageal cancer

inferred← citeshttps://doi.org/10.1007/s11060-017-2390-3openalex-snapshot

Immune checkpoint inhibition and its relationship with hypermutation phenoytype as a potential treatment for Glioblastoma

inferred← citeshttps://doi.org/10.1007/s11060-019-03355-0openalex-snapshot

Tumor immune microenvironment is associated with the growth of intracranial germinomas

inferred← citeshttps://doi.org/10.1007/s11427-012-4379-7openalex-snapshot

Cross-reactivity of anti-programmed death ligand 2 polyclonal antibody in mouse tissues

inferred← citeshttps://doi.org/10.1007/s11596-009-0116-2openalex-snapshot

Costimulatory molecule B7-H1 on the immune escape of bladder cancer and its clinical significance

inferred← citeshttps://doi.org/10.1007/s11596-011-0476-2openalex-snapshot

Relatively increased number of liver Foxp3+ regulatory T cells against hepatic lesions in murine lupus

inferred← citeshttps://doi.org/10.1007/s11626-024-00869-4openalex-snapshot

Programmed cell death-1-modified pig developed using electroporation-mediated gene editing for in vitro fertilized zygotes

inferred← citeshttps://doi.org/10.1007/s11739-020-02295-2openalex-snapshot

Management of immune-related adverse events associated with immune checkpoint inhibitors in cancer patients: a patient-centred approach

inferred← citeshttps://doi.org/10.1007/s11864-020-00733-zopenalex-snapshot

Current Treatment of Melanoma Brain Metastasis

inferred← citeshttps://doi.org/10.1007/s11864-020-0721-7openalex-snapshot

Cutaneous Adverse Events of Anti-PD-1 Therapy and BRAF Inhibitors

inferred← citeshttps://doi.org/10.1007/s11864-023-01130-yopenalex-snapshot

Update on Immunotherapy Cardiotoxicity: Checkpoint Inhibitors, CAR T, and Beyond

inferred← citeshttps://doi.org/10.1007/s11912-012-0284-2openalex-snapshot

Programmed Death 1 Pathway inhibition in Metastatic Renal Cell Cancer and Prostate Cancer

inferred← citeshttps://doi.org/10.1007/s11912-017-0625-2openalex-snapshot

Cancer Clonal Theory, Immune Escape, and Their Evolving Roles in Cancer Multi-Agent Therapeutics

inferred← citeshttps://doi.org/10.1007/s12026-022-09302-yopenalex-snapshot

Soluble PD-L1 in blood correlates positively with neutrophil and negatively with lymphocyte mRNA markers and implies adverse sepsis outcome

inferred← citeshttps://doi.org/10.1007/s12032-017-0899-0openalex-snapshot

Oncolytic viruses: emerging options for the treatment of breast cancer

inferred← citeshttps://doi.org/10.1007/s12032-017-0941-2openalex-snapshot

Prognostic significance of PD-L1 expression on tumor cells and tumor-infiltrating mononuclear cells in upper tract urothelial carcinoma

inferred← citeshttps://doi.org/10.1007/s12032-019-1246-4openalex-snapshot

Deficiency of mismatch repair genes is less frequently observed in signet ring cell compared with non-signet ring cell gastric cancer

inferred← citeshttps://doi.org/10.1007/s12032-023-01992-0openalex-snapshot

Role of epigenetics in OSCC: an understanding above genetics

inferred← citeshttps://doi.org/10.1007/s12032-024-02588-yopenalex-snapshot

Nanobodies as innovative immune checkpoint modulators: advancing cancer immunotherapy

inferred← citeshttps://doi.org/10.1007/s12035-021-02495-7openalex-snapshot

Role of the PD‐1/PD‐L1 Signaling in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Recent Insights and Future Directions

inferred← citeshttps://doi.org/10.1007/s12072-026-11152-xopenalex-snapshot

Clinical and pathological significance of serum anti-PD-1 autoantibodies in acute-onset and chronic autoimmune hepatitis

inferred← citeshttps://doi.org/10.1007/s12094-017-1827-7openalex-snapshot

Perspective on immune oncology with liquid biopsy, peripheral blood mononuclear cells, and microbiome with non-invasive biomarkers in cancer patients

inferred← citeshttps://doi.org/10.1007/s12104-022-10092-5openalex-snapshot

Sequence-specific 1H, 13C and 15N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1

inferred← citeshttps://doi.org/10.1007/s12105-017-0857-3openalex-snapshot

Beyond the Percentages of PD-L1-Positive Tumor Cells: Induced Versus Constitutive PD-L1 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma

inferred← citeshttps://doi.org/10.1007/s12272-010-1115-3openalex-snapshot

Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes

inferred← citeshttps://doi.org/10.1007/s12275-015-5022-7openalex-snapshot

The role of programmed death ligand 1 pathway in persistent biomaterial-associated infections

inferred← citeshttps://doi.org/10.1007/s12328-021-01542-zopenalex-snapshot

Nivolumab dose escalation triggered immune checkpoint inhibitor-induced colitis after 147 weeks of prolonged stable use in a patient with lung cancer: a case report

inferred← citeshttps://doi.org/10.1007/s12328-022-01680-yopenalex-snapshot

A rare case of eosinophilic gastritis induced by nivolumab therapy for metastatic melanoma

inferred← citeshttps://doi.org/10.1007/s12672-025-01749-3openalex-snapshot

Hyperprogressive disease induced by PD-1 inhibitor monotherapy in lung adenocarcinoma with HER2 exon 20 insertion: report of two cases and review of literature

inferred← citeshttps://doi.org/10.1007/s12672-025-01889-6openalex-snapshot

A novel golgi related genes based correlation prognostic index can better predict the prognosis of glioma and responses to immunotherapy

inferred← citeshttps://doi.org/10.1007/s13277-013-1006-6openalex-snapshot

T-cell infiltration and expressions of T lymphocyte co-inhibitory B7-H1 and B7-H4 molecules among colorectal cancer patients in northeast China’s Heilongjiang province

inferred← citeshttps://doi.org/10.1007/s13277-015-4622-5openalex-snapshot

Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma

inferred← citeshttps://doi.org/10.1007/s13311-022-01184-0openalex-snapshot

Paraneoplastic Autoimmune Neurological Syndromes and the Role of Immune Checkpoint Inhibitors

inferred← citeshttps://doi.org/10.1007/s13353-023-00807-2openalex-snapshot

lncRNA MIAT promotes luminal B breast cancer cell proliferation, migration, and invasion in vitro

inferred← citeshttps://doi.org/10.1007/s40257-013-0025-9openalex-snapshot

Optimal Management of Metastatic Melanoma: Current Strategies and Future Directions

inferred← citeshttps://doi.org/10.1007/s40264-018-0774-8openalex-snapshot

Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer

inferred← citeshttps://doi.org/10.1007/s40265-017-0734-0openalex-snapshot

Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies

inferred← citeshttps://doi.org/10.1007/s43152-023-00052-zopenalex-snapshot

Tumor Microenvironment Regulates Immune Checkpoints: Emerging Need of Combinatorial Therapies

inferred← citeshttps://doi.org/10.1016/b978-0-12-370454-2.00029-6openalex-snapshot

NK cells in the eye

inferred← citeshttps://doi.org/10.1016/b978-0-12-397933-9.00016-3openalex-snapshot

The Mucosal Immune System

inferred← citeshttps://doi.org/10.1016/b978-0-12-801899-6.00005-xopenalex-snapshot

Biomarkers and Methodologies for Monitoring Epigenetic Drug Effects in Cancer

inferred← citeshttps://doi.org/10.1016/b978-0-12-812896-1.00040-4openalex-snapshot

References

inferred← citeshttps://doi.org/10.1016/b978-0-12-813339-2.00003-7openalex-snapshot

Single and Multiphoton Responsive Nanomaterials for the Investigation of Cancer Microenvironment

inferred← citeshttps://doi.org/10.1016/b978-0-12-816386-3.00056-9openalex-snapshot

Theranostic Approaches Using Live Bacteria

inferred← citeshttps://doi.org/10.1016/b978-0-12-820141-1.00009-1openalex-snapshot

Tailoring peptides and peptidomimetics for targeting protein–protein interactions

inferred← citeshttps://doi.org/10.1016/b978-0-12-820683-6.00015-4openalex-snapshot

Autoimmune diabetes insipidus

inferred← citeshttps://doi.org/10.1016/b978-0-12-822803-6.00007-7openalex-snapshot

Therapeutic strategies

inferred← citeshttps://doi.org/10.1016/b978-0-12-824465-4.00260-xopenalex-snapshot

Autoimmunity – Diseases of the EYE

inferred← citeshttps://doi.org/10.1016/b978-0-323-47674-4.00006-2openalex-snapshot

Cancer Immunology

inferred← citeshttps://doi.org/10.1016/b978-0-323-47674-4.00079-7openalex-snapshot

Cancer of the Kidney

inferred← citeshttps://doi.org/10.1016/b978-0-323-54948-6.00004-4openalex-snapshot

Immune Checkpoint Inhibitors in Gastrointestinal Malignancies

inferred← citeshttps://doi.org/10.1016/b978-0-323-76097-3.00024-7openalex-snapshot

Endocrinopathies Associated With Immune Checkpoint Inhibitors

inferred← citeshttps://doi.org/10.1016/b978-0-443-23523-8.00011-0openalex-snapshot

Managing adverse effects of novel immunotherapy in pancreatic cancer

inferred← citeshttps://doi.org/10.1016/b978-0-443-23523-8.00015-8openalex-snapshot

Targeting Tregs in pancreatic ductal adenocarcinoma

inferred← citeshttps://doi.org/10.1016/b978-1-4557-2865-7.00006-0openalex-snapshot

Cancer Immunology

inferred← citeshttps://doi.org/10.1016/b978-1-4557-2865-7.00082-5openalex-snapshot

Cancer of the Kidney

inferred← citeshttps://doi.org/10.1016/b978-1-4557-4066-6.00052-4openalex-snapshot

Cancer Immunotherapy with Vaccines and Checkpoint Blockade

inferred← citeshttps://doi.org/10.1016/bs.acr.2015.04.010openalex-snapshot

The New Era of Cancer Immunotherapy

inferred← citeshttps://doi.org/10.1016/bs.ircmb.2016.12.001openalex-snapshot

Cellular and Molecular Mechanisms of Autoimmunity and Lupus Nephritis

inferred← citeshttps://doi.org/10.1016/bs.pmbts.2024.01.003openalex-snapshot

RNA therapeutics in cancer treatment

inferred← citeshttps://doi.org/10.1016/j.actbio.2021.09.040openalex-snapshot

Coadministration of iRGD peptide with ROS-sensitive nanoparticles co-delivering siFGL1 and siPD-L1 enhanced tumor immunotherapy

inferred← citeshttps://doi.org/10.1016/j.acuro.2020.06.011openalex-snapshot

Nuevas inmunoterapias en el cáncer de vejiga no músculo-invasivo de alto riesgo: estado actual y perspectivas de futuro

showing the first 200 of 1279

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.